A Pilot Trial of Remotely-Supervised Transcranial Direct Current Stimulation (RS-tDCS) to Enhance Motor Learning in Progressive Multiple Sclerosis (MS)
Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
NYU Langone Health
Age
18–70
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Definite MS diagnosis, progressive subtype
9HPT score between -1.0 and -4.0 standard deviations from age-based normative data
Score of \< 7.5 or less on the EDSS (with caregiver proxy required for those with scores of 6.5 or greater)\*
Ability to understand the informed consent process and provide consent to participate in the study
You may not be if
Primary neurologic, psychiatric or other medical disorder other than MS
Use of upper extremity Botox injection within 3 months
Current use of intrathecal Baclofen
History of seizure disorder
History of head trauma or medical device in head or neck
Clinically significant abnormality on EKG
Symbol Digit Modalities Test or SDMT score ≥3.0 SD from published norms
WRAT-4 reading level below average (\<85) (estimated general intellectual function)
Skin disorder/sensitive near stimulation locations
Clareo Health | A Pilot Trial of Remotely-Supervised Transcranial Direct Current Stimulation (RS-tDCS) to Enhance Motor Learning in Progressive Multiple Sclerosis (MS)
